Matouk Bassiouny & Hennawy Advised Triquera B.V. on Minority Stake Subscription by Admaius Capital Partners
The leading law firm in the MENA region, Matouk Bassiouny & Hennawy (“MBH”), acted as legal counsel to Triquera B.V. (“Triquera”), the majority shareholder of Minapharm Pharmaceuticals (“Minapharm”), in connection with the subscription of a minority stake by Admaius Capital Partners (“Admaius”), an Africa-focused private equity investor.
The investment, executed through Admaius’s investment vehicle Virunga Healix Limited, is intended to support Minapharm’s regional biotech expansion. Triquera and Admaius will partner to advance the development and manufacture of complex genetically engineered therapies. The collaboration aims to broaden access to high-quality, affordable recombinant proteins, reflecting both parties’ commitment to innovation and inclusive healthcare by scaling distribution networks across underserved markets in Africa and the Middle East.
The MBH team advising on the transaction was led by Omar S. Bassiouny (Founding Partner and Group Head of Corporate and M&A), with support from Salma El Refaie (Senior Associate) and Mayar Sharafeldin (Associate).
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at [email protected] or call us on +91 8879634922.